Literature DB >> 7439478

PUVA treatment for alopecia areata.

A Lassus, U Kianto, E Johansson, T Juvakoski.   

Abstract

41 patients with severe alopecia areata were treated with either local or oral 8-methoxypsoralen and UVA irradiations. In 26 cases (73%) a good to excellent result was obtained. The number of irradiations required for regrowth varied but 20--40 treatments were sufficient in most cases with a positive response. Patients with circumscribed or ophiasic alopecia responded better than patients with total or universal alopecia, atopy or a family history of alopecia did not seem to influence the outcome of the treatment. The age of onset of the disease seemed to be of importance as well as the duration of the treated attack. Patients over 20 years at the first attack of alopecia showed a better response than patients with an earlier onset of the disease. During a follow-up period of 6--12 months of 20 successfully treated patients only 2 had a recurrence.

Entities:  

Mesh:

Year:  1980        PMID: 7439478     DOI: 10.1159/000250381

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  4 in total

1.  Hypertrichosis: a side-effect of PUVA therapy.

Authors:  F H Rampen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Effectiveness of Paint Psoralen and Ultraviolet-A in Alopecia Areata - Our Experience in the National Skin Center.

Authors:  Lucinda Siyun Tan; Melissa Mei Hsia Chan; Daryl Jian An Tan; Joyce Siong See Lee; Wei-Sheng Chong
Journal:  Indian J Dermatol       Date:  2020 May-Jun       Impact factor: 1.494

3.  Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design.

Authors:  Kui Young Park; Woo Sun Jang; In Pyeong Son; Sun Young Choi; Moo Yeol Lee; Beom Joon Kim; Myeung Nam Kim; Byung In Ro
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

4.  308-nm Excimer Lamp for the Treatment of Alopecia Areata: Clinical Trial on 16 Cases.

Authors:  Akiko Ohtsuki; Toshio Hasegawa; Etsuko Komiyama; Atsushi Takagi; Junko Kawasaki; Shigaku Ikeda
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.